References
- BrownABMeltzerDOChinMHHuangESPerceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patientsJ Am Geriatr Soc2008561183119018492034
- SloanFAPadrònNAPlattACPreferences, beliefs, and self-management of diabetesHealth Serv Res2009441068108719674433
- McGlynnEAschSAdamsJThe quality of health care delivered to adults in the United StatesN Engl J Med20033482635264512826639
- AndersonRTSkovlundSEMarreroDDevelopment and validation of the Insulin Treatment Satisfaction QuestionnaireClin Ther20042656557815189754
- LingvayILegendreJLKaloyanovaPFZhangSAdams-HuetBRaskinPInsulin-based versus triple oral therapy for newly diagnosed Type 2 diabetes: Which is betterDiabetes Care2009321789179519592630
- MatzaLSBoyeKSYurginNUtilities and disutilities for type 2 diabetes treatment-related attributesQual Life Res2007161251126517638121
- HuangESShookMJinLChinMHMeltzerDOThe impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetesDiabetes Care20062925926416443870
- HutchinsonAMcIntoshAPetersJClinical Guidelines and Evidence Review for Type 2 Diabetes. Diabetic retinopathy: Early management and screeningSheffield, UKScHARR, University of Sheffield2001
- LeeJBaileyGDiabetic retinopathy Access Media Group LLC, c2000–10 [Updated 2007 June]. Available from: http://www.allaboutvision.com/conditions/diabetic.htm. Accessed 2008 Sep 16.
- KleinRKleinBEKMossSECruickshanksKJThe Wisconsin epidemiologic-study of diabetic retinopathy: The long-term incidence of macular edemaOphthalmology19951027167831044
- SaaddineJBHoneycuttAANarayanKMProjection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005–2050Arch Ophthalmol20081261740174719064858
- SammartinCGilmoreJStatistics Canada. Diabetes care in Canada: Results from selected provinces and territory, 2005 [Updated 2006 Oct 20] Available from: http://www.statcan.gc.ca/pub/82-621-x/2006002/4053724-eng.htm#source. Accessed 2008 Sep 16.
- Early Treatment Diabetic Retinopathy Study (ETDRS) research groupPhotocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1Arch Ophthalmol1985103179618062866759
- FerrisFLIIIHow effective are treatments for diabetic retinopathyJAMA1993269129012918437309
- HanYSchneckMEBearseMAFormulation and evaluation of a predictive model to identify the sites of future diabetic retinopathyInvest Ophthalmol Vis Sci2004454106411215505062
- ChurchillAJCarterJGRamsdenCVEGF polymorphisms are associated with severity of diabetic retinopathyInvest Ophthalmol Vis Sci2008493611361618441306
- Diabetic Retinopathy Study Research GroupPreliminary report on effects of photocoagulation therapyAm J Ophthalmol197681383396944535
- ChalamKVLinSMostafaSManagement of diabetic retinopathy in the twenty-first centuryNortheast Florida Medicine20055692815
- DowlerJLaser management of diabetic retinopathyJournal of the Royal Society of Medicine200396277279 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=539507. Accessed 2010 Aug 28.12782691
- Early Treatment of Diabetic Retinopathy Study Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9Ophthalmology1991987667852062512
- WirostkoBWongTSimoRVascular endothelial growth factor and diabetic complicationsProg Retin Eye Res20082760862118929676
- BrunnerSSchernthanerGSatlerMCorrelation of different circulating endothelial progenitor cells to stages of diabetic retinopathy – first in vivo dataInvest Ophthalmol Vis Sci20095039239818719083
- GreenPESrinivasanVConjoint analysis in marketing: New developments with implications for research and practiceJournal of Marketing1990543517
- RyanMFarrarSUsing conjoint analysis to elicit preferences for health careBMJ20003201530153310834905
- BeusterienKMDziekanKFloodEUnderstanding patient preferences for HIV medications using adaptive conjoint analysis: Feasibility assessmentValue Health2005845346116091022
- BhargavaJSPatelBFossAJViews of glaucoma patients on aspects of their treatment: An assessment of patient preference by conjoint analysisInvest Ophthalmol Vis Sci2006472885288816799029
- BlankenshipGWDiabetic macular edema and Argon laser photocoagulation: A prospective randomized studyOphthalmology1979866975530565
- FongDSGirachABoneyAVisual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: A literature reviewRetina20072781682417891003
- MargolisRSinghRBhatnagarPKaiserPIntravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedemaActa Ophthalmol Scand20081105110
- SutterFSimpsonJGilliesMIntravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trialOphthalmology20041112044204915522370
- MohamedQGilliesMWongTManagement of diabetic retinopathy: A systematic reviewJAMA200729890291617712074
- SeiberthVAlexandridisEFunction of the diabetic retina after panretinal argon laser photocoagulation. Influence of the intensity of the coagulation spotsOphthalmologica199120210172017326
- SeiberthVSchatanekSAlexandridisEPanretinal photocoagulation in diabetic retinopathy: Argon versus dye laser coagulationGraefes Arch Clin Exp Ophthalmol19932313183228339946
- FraenkelLBogardusSTConcatoJFelsonDTWittinkDRPatient preferences for treatment of rheumatoid arthritisAnn Rheum Dis2004631372137815020312
- ACA Technical PaperSawtooth SoftwareSequim, WA Available from: http://www.sawtoothsoftware.com. Accessed 2008 Nov 13.
- KleinKSWalshMKHassanTSEndophthalmitis after anti-VEGF injectionsOphthalmology20091161225.e119486799
- ArtunayOYuzbasiogluERasierRSengülABahceciogluHIncidence and management of acute endophthalmitis after intraviteral bevacizumab (Avastin) injectionEye2009232187219319218994